Literature DB >> 3335810

Herpes zoster in African patients: a clinical predictor of human immunodeficiency virus infection.

R Colebunders1, J M Mann, H Francis, K Bila, L Izaley, M Ilwaya, N Kakonde, T C Quinn, J W Curran, P Piot.   

Abstract

A recent episode or a history of herpes zoster was found in 30 (11%) of 284 patients hospitalized with human immunodeficiency virus (HIV) infection at Mama Yemo Hospital, Kinshasa, Zaire. Of 146 African patients with a history of herpes zoster who were referred to us by physicians at the Mama Yemo Hospital, 133 (91%) were HIV seropositive. The clinical characteristics of the herpes zoster episodes did not differ between HIV-seropositive and -seronegative individuals, except that 23% of the HIV-seropositive patients experienced recurrences compared with none of the HIV-seronegative patients (P = .05). No patient developed a generalized herpes zoster eruption, and only patients with ophthalmic zoster developed related complications. Patients who experienced severe pain during their herpes zoster attack lost more weight than did those who had only minor pain (P = .0003).

Entities:  

Mesh:

Year:  1988        PMID: 3335810     DOI: 10.1093/infdis/157.2.314

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  21 in total

1.  A 26-year-old woman presented to Kijabe Mission Hospital with a diffuse rash and dyspnea.

Authors:  Jon F Fielder
Journal:  MedGenMed       Date:  2005-07-13

2.  Herpes zoster and the stage and prognosis of HIV-1 infection.

Authors:  A McNulty; Y Li; U Radtke; J Kaldor; R Rohrsheim; D A Cooper; B Donovan
Journal:  Genitourin Med       Date:  1997-12

3.  Orocutaneous Manifestations as Markers of Disease Progression in HIV Infection in Indian Setting.

Authors:  Y K Sharma; Mps Sawhney; D S Bhakuni; V Gera
Journal:  Med J Armed Forces India       Date:  2011-07-21

4.  The herpes simplex virus immediate-early protein, ICP4, is required to potentiate replication of human immunodeficiency virus in CD4+ lymphocytes.

Authors:  M A Albrecht; N A DeLuca; R A Byrn; P A Schaffer; S M Hammer
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

5.  DERMATOMAL AND DISSEMINATED VARICELLA ZOSTER LESIONS IN A HIV INFECTED INDIVIDUAL: A Case Report.

Authors:  Rajesh Chauhan; R P Singh; A K Hooda; Vijay Vadhera; V P Singh; Dms Mabena
Journal:  Med J Armed Forces India       Date:  2017-06-26

6.  HERPES ZOSTER IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION.

Authors:  P C Sanchetee; Y D Singh
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 7.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

Review 8.  Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus.

Authors:  J W Tappero; B A Perkins; J D Wenger; T G Berger
Journal:  Clin Microbiol Rev       Date:  1995-07       Impact factor: 26.132

9.  Disseminated herpes zoster with increased CD4 counts in 3 HIV-infected patients.

Authors:  Pooja Lidhoo; Patrick Unemori; Kieron S Leslie; Toby Maurer
Journal:  J Am Acad Dermatol       Date:  2009-08       Impact factor: 11.527

10.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.